AR070759A1 - Composicion que comprende acidos grasos poliinsaturados y carbon vegetal activado - Google Patents
Composicion que comprende acidos grasos poliinsaturados y carbon vegetal activadoInfo
- Publication number
- AR070759A1 AR070759A1 ARP080104763A ARP080104763A AR070759A1 AR 070759 A1 AR070759 A1 AR 070759A1 AR P080104763 A ARP080104763 A AR P080104763A AR P080104763 A ARP080104763 A AR P080104763A AR 070759 A1 AR070759 A1 AR 070759A1
- Authority
- AR
- Argentina
- Prior art keywords
- fatty acids
- composition
- vegetable carbon
- bad
- activated vegetable
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/201—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
- A61K31/232—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms having three or more double bonds, e.g. etretinate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/44—Elemental carbon, e.g. charcoal, carbon black
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Cardiology (AREA)
- Inorganic Chemistry (AREA)
- Emergency Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Medicinal Preparation (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Se refiere a una composicion oral sin mal aroma, mal olor o mal sabor que comprende ácidos grasos poliinsaturados (PUFA) y carbon vegetal activado, su procedimiento de preparacion y su uso como suplemento nutricional o como suplemento dietético para equilibrar el nivel de lípidos en sangre, prevenir o reducir el riesgo de desarrollo de cambios, trastornos o enfermedades ateroscleroticos.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP07291306 | 2007-10-30 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR070759A1 true AR070759A1 (es) | 2010-05-05 |
Family
ID=40344798
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP080104763A AR070759A1 (es) | 2007-10-30 | 2008-10-30 | Composicion que comprende acidos grasos poliinsaturados y carbon vegetal activado |
Country Status (15)
Country | Link |
---|---|
US (1) | US20100260893A1 (es) |
EP (1) | EP2214638B1 (es) |
AR (1) | AR070759A1 (es) |
AT (1) | ATE541560T1 (es) |
AU (1) | AU2008317920B2 (es) |
BR (1) | BRPI0818568A2 (es) |
CA (1) | CA2703816C (es) |
ES (1) | ES2379034T3 (es) |
MX (1) | MX2010003703A (es) |
PE (1) | PE20091076A1 (es) |
PL (1) | PL2214638T3 (es) |
RU (1) | RU2485940C2 (es) |
TW (1) | TW200942229A (es) |
UY (1) | UY31410A1 (es) |
WO (1) | WO2009056247A1 (es) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9610313B2 (en) | 2008-04-10 | 2017-04-04 | U.S. Nutraceuticals | Eye health composition and method using plant derived seed extract rich in essential fatty acids derived from perilla seed and carotenoids |
US9770047B2 (en) | 2008-04-10 | 2017-09-26 | U.S. Nutraceuticals, LLC | Perilla seed composition |
US8784904B2 (en) | 2008-04-10 | 2014-07-22 | U.S. Nutraceuticals, LLC | Plant derived seed extract rich in essential fatty acids derived from perilla seed: composition of matter, manufacturing process and use |
US8586104B2 (en) | 2008-04-10 | 2013-11-19 | U.S. Nutraceuticals, LLC | Plant derived seed extract rich in essentially fatty acids derived from Salvia hispanica L. seed: composition of matter, manufacturing process and use |
EP2595609A4 (en) * | 2010-07-01 | 2014-04-16 | Delante Health As | COVERED EFFERVESCENT TABLET |
US20130115306A1 (en) * | 2011-11-09 | 2013-05-09 | Denovo Inc. | Toxin decontaminant food product and method of treating disorders of the gastrointestinal tract |
RU2524358C2 (ru) * | 2012-07-24 | 2014-07-27 | Федеральное государственное бюджетное учреждение "Научно-исследовательский институт питания РАМН" Российской академии медицинских наук (ФГБУ "НИИ питания" РАМН) | Функциональный пищевой ингредиент с заданным липидным профилем |
CN105339006A (zh) * | 2013-05-10 | 2016-02-17 | 尼特罗米加公司 | 含有脂肪酸和亚硝酸盐的营养或膳食补充剂 |
EA025006B1 (ru) * | 2013-08-22 | 2016-11-30 | Федеральное государственное бюджетное учреждение "Научно-исследовательский институт питания РАМН" Российской академии медицинских наук (ФГБУ "НИИ питания" РАМН) | Функциональный пищевой ингредиент с заданным липидным профилем |
CN105935145B (zh) * | 2015-12-18 | 2019-09-20 | 重庆两江药物研发中心有限公司 | 一种鱼油植物甾醇复合片剂及其制备方法 |
CN105919946B (zh) * | 2016-05-31 | 2019-03-12 | 福格森(武汉)生物科技股份有限公司 | 一种dha微丸的制备方法 |
EA201991467A1 (ru) * | 2016-12-15 | 2019-11-29 | Состав смеси, содержащий силикат и микробные и/или растительные клетки и полиненасыщенную жирную кислоту, имеющую по меньшей мере 20 атомов углерода (lc-pufa) | |
CN111067876B (zh) * | 2019-12-04 | 2022-08-16 | 宁夏大学 | 一种α-亚麻酸双层片及其制备方法 |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3702031A1 (de) | 1987-01-24 | 1988-08-04 | Basf Ag | Verfahren zur herstellung von mikrodispersen fischoelpraeparaten |
US5780039A (en) * | 1992-04-23 | 1998-07-14 | Novartis Nutrition Ag | Orally-ingestible nutrition compositions having improved palatability |
JPH0892587A (ja) | 1994-09-22 | 1996-04-09 | Baiotsukusu:Kk | 魚臭のマスキング法 |
JP3534881B2 (ja) | 1995-02-23 | 2004-06-07 | 太陽化学株式会社 | 乳化組成物 |
US6630192B2 (en) | 1995-04-07 | 2003-10-07 | Brandeis University | Increasing the HDL level and the HDL/LDL ratio in human serum by balancing saturated and polyunsaturated dietary fatty acids |
IL131126A (en) * | 1997-02-21 | 2003-04-10 | Abbott Lab | Compositions for reducing the incidence of necrotizing enterocolitis and the preparation thereof |
US6479545B1 (en) * | 1999-09-30 | 2002-11-12 | Drugtech Corporation | Formulation for menopausal women |
ATE301401T1 (de) | 2000-05-18 | 2005-08-15 | Mega Healthcare As Q | Nahrungsergänzungsmittel mit vitaminen, mineralien und mehrfach ungesättigten fettsäuren |
JP2002204656A (ja) | 2001-01-10 | 2002-07-23 | Yakult Honsha Co Ltd | 発酵乳飲食品及びその製造方法 |
DE20105126U1 (de) * | 2001-03-23 | 2002-01-31 | Bartz, Volker, 35440 Linden | Fischöl zur oralen Einnahme |
EP1399309A1 (en) * | 2001-06-25 | 2004-03-24 | Pharmacia Corporation | Compression coated tablets |
DE60301677T2 (de) * | 2002-02-04 | 2006-07-06 | Kyowa Hakko Kogyo Co., Ltd. | Pharmazeutische und Lebenmittelzusammensetzungen mit einem Di- oder Oligosaccharid, das die Insulinfreisetzung steigert |
WO2004026950A2 (en) * | 2002-08-14 | 2004-04-01 | E.I. Du Pont De Nemours And Company | Solid flowable powder with high liquid loading |
WO2004016720A2 (en) | 2002-08-14 | 2004-02-26 | E.I. Du Pont De Nemours And Company | Coated polyunsaturated fatty acid-containing particles and coated liquid pharmaceutical-containing particles |
EP1670324A1 (en) | 2003-09-26 | 2006-06-21 | Nestec S.A. | Nutritional composition with unsaturated fatty acids and trace elements |
SI1566173T1 (sl) * | 2004-02-20 | 2006-12-31 | Mattern Udo | Farmacevtska zmes za oralno aplikacijo in postopek njene priprave |
US20060083786A1 (en) * | 2004-07-29 | 2006-04-20 | Glenmark Pharmaceuticals Limited | Taste masking pharmaceutical composition containing levocetirizine |
KR20080046649A (ko) * | 2005-08-03 | 2008-05-27 | 사솔 테크놀로지(프로프라이어터리) 리미티드 | 초대형 용기의 운송 및 건조 |
GB0516069D0 (en) * | 2005-08-04 | 2005-09-14 | Imp College Innovations Ltd | Pharmaceutical and use thereof |
-
2008
- 2008-10-20 UY UY31410A patent/UY31410A1/es not_active Application Discontinuation
- 2008-10-21 MX MX2010003703A patent/MX2010003703A/es active IP Right Grant
- 2008-10-21 RU RU2010121714/15A patent/RU2485940C2/ru active
- 2008-10-21 CA CA2703816A patent/CA2703816C/en active Active
- 2008-10-21 ES ES08845987T patent/ES2379034T3/es active Active
- 2008-10-21 EP EP08845987A patent/EP2214638B1/en active Active
- 2008-10-21 AT AT08845987T patent/ATE541560T1/de active
- 2008-10-21 PL PL08845987T patent/PL2214638T3/pl unknown
- 2008-10-21 AU AU2008317920A patent/AU2008317920B2/en active Active
- 2008-10-21 PE PE2008001803A patent/PE20091076A1/es not_active Application Discontinuation
- 2008-10-21 BR BRPI0818568 patent/BRPI0818568A2/pt not_active Application Discontinuation
- 2008-10-21 WO PCT/EP2008/008882 patent/WO2009056247A1/en active Application Filing
- 2008-10-29 TW TW097141493A patent/TW200942229A/zh unknown
- 2008-10-30 AR ARP080104763A patent/AR070759A1/es unknown
-
2010
- 2010-04-30 US US12/799,744 patent/US20100260893A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
CA2703816A1 (en) | 2009-05-07 |
ATE541560T1 (de) | 2012-02-15 |
RU2485940C2 (ru) | 2013-06-27 |
ES2379034T3 (es) | 2012-04-20 |
CA2703816C (en) | 2016-07-19 |
TW200942229A (en) | 2009-10-16 |
WO2009056247A1 (en) | 2009-05-07 |
PE20091076A1 (es) | 2009-07-25 |
UY31410A1 (es) | 2009-05-29 |
EP2214638A1 (en) | 2010-08-11 |
AU2008317920B2 (en) | 2014-03-13 |
MX2010003703A (es) | 2010-07-30 |
US20100260893A1 (en) | 2010-10-14 |
BRPI0818568A2 (pt) | 2015-04-22 |
PL2214638T3 (pl) | 2012-06-29 |
EP2214638B1 (en) | 2012-01-18 |
RU2010121714A (ru) | 2011-12-10 |
AU2008317920A1 (en) | 2009-05-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR070759A1 (es) | Composicion que comprende acidos grasos poliinsaturados y carbon vegetal activado | |
WO2007092509A3 (en) | Dietary supplement composition for blood lipid health | |
UY31411A1 (es) | Composicion orodispersable sin mal olor o mal sabor que comprende acidos grasos poliinsaturados | |
WO2010149895A3 (fr) | Extrait de graines entieres de moringa sp et son utilisation dans des compositions cosmetiques et/ou dermatologiques | |
EA201071206A1 (ru) | Композиции, содержащие липид, и способы их применения | |
EP2946784A3 (en) | A therapeutic composition comprising salmon oil and extracts of rosemary and oregano | |
AR051420A1 (es) | Procesos para la preparacion de composiciones oleosas | |
PH12017500074A1 (en) | Nutritional compositions containing oil blends and uses thereof | |
BRPI0814726A2 (pt) | fortificação de produtos nutricionais com extratos de oliveiras contendo hidroxitirosol e produtos nutricionais fortificados com hidroxitirosol | |
EA200970238A1 (ru) | ПРИМЕНЕНИЕ МАСЕЛ С DPA(n-6) В ДЕТСКОМ ПИТАНИИ | |
BRPI0508872A (pt) | composição emulsificante para gordura | |
WO2011097273A8 (en) | Methods and compositions for treating non-alcoholic fatty liver disease with docosahexaenoic acid and n-acetyl l-cysteine | |
MX2010006130A (es) | Producto alimenticio que incluye uno o mas acidos grasos omega-3 y uno o mas sabores de fruta. | |
AR063024A1 (es) | Composicion sin sabor metalico | |
Hernández et al. | Extraction and characterization of Oecopetalum mexicanum seed oil | |
BR112012007166A2 (pt) | "composição de gordura alimentícia, método de uso de ácido estearidônico para formar uma composição de gordura alimentícia,composições alimentícias, manteiga de nozes e metodo para usar ácido esteardônico para formar uma manteiga de nozes. | |
FR2899768A1 (fr) | Complement alimentaire antioxydant contenant des oligoproanthocyanides, du gamma-tocopherol, des catechines et biflavanes, de l'acide carnosique et du carnosol | |
CO6341531A2 (es) | Producto alimenticio de acidos grasos con base de chia, rico en omega-3, con buena estabilidad | |
RU2013125980A (ru) | Подсолнечник с низким содержанием насыщенных жиров и соответствующие способы | |
SE0201566D0 (sv) | New composition | |
Lee et al. | Quality evaluation of Perilla seed Gangjung added with mealworm powder | |
AR069906A1 (es) | Producto alimenticio que incluye uno o mas acidos grasos omega 3 encapsulados y uno o mas sabores a fruta | |
WO2010133377A8 (en) | Fat blends and uses thereof | |
RU2009107155A (ru) | Антиоксидантное лекарственное средство на основе спиртовых отходов | |
Mataix et al. | Virgin olive oil: a key healthy component of the Mediterranean diet |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |